Table 3

Sensitivity and specificity of candidate criteria: nr-axSpA versus NSBP

CohortAB
SensSpec (NSBP+HC)LR+LR−SensSpecLR+LR−
Global assessment0.740.95 (0.94)14.380.280.440.832.500.68
ASAS definition0.800.76 (0.74)3.280.260.420.741.580.79
MORPHO definition0.880.72 (0.71)3.170.170.540.721.930.64
ER ≥20.580.97 (0.97)17.940.440.300.903.030.78
BMO ≥20.800.76 (0.74)3.370.260.420.731.540.80
BMO ≥2 and/or ER ≥10.880.72 (0.71)3.170.170.550.701.810.65
BMO ≥2 and/or ER ≥20.880.73 (0.72)3.250.170.530.711.850.66
BMO ≥30.750.89 (0.88)6.500.280.340.842.130.79
BMO ≥3 and/or ER ≥10.830.85 (0.84)5.360.210.480.792.240.67
BMO ≥3 and/or ER ≥20.830.85 (0.85)5.600.210.460.822.530.66
BMO ≥40.700.92 (0.92)9.100.320.270.872.130.83
BMO ≥4 and/or ER ≥10.780.88 (0.88)6.360.260.440.802.130.71
BMO ≥4 and/or ER ≥20.780.89 (0.89)7.110.250.420.832.520.70
  • Sensitivity, specificity and likelihood ratios are expressed as mean values over four readers. The gold standard for calculating sensitivity and specificity was rheumatologist expert opinion.

  • ASAS, Assessment in SpondyloArthritis international Society definition: ≥2 SIJ quadrants with BMO on the same MRI slice or BMO in the same SIJ quadrant on ≥2 consecutive MRI slices; BMO, bone marrow oedema; ER, erosion; HC, healthy control; LR−, negative likelihood ratio; LR+, positive likelihood ratio; MORPHO definition, ≥2 SIJ quadrants with BMO on the same MRI slice or BMO in the same SIJ quadrant on ≥2 consecutive MRI slices or ≥2 SIJ quadrants with erosion on the same MRI slice or erosion in the same SIJ quadrant on ≥2 consecutive MRI slices or ≥1 SIJ quadrant with BMO plus ≥1 SIJ quadrant with erosion4; MRI, magnetic resonance imaging; nr-axSpA, non-radiographic axial spondyloarthritis; NSBP, non-specific back pain; Sens, sensitivity; SIJ, sacroiliac joint; Spec, specificity.